Notice of Intent to Sole Source – Life Technologies Corp.
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH - CC
Contract Value
Not provided
Codes & Classification
Solicitation Number
26-001503
NAICS
339112 - Surgical and Medical Instrument Manufacturing
Classification Code
6515
Additional Details
The National Institutes of Health (NIH) Clinical Center, Department of Laboratory Medicine (DLM), has issued a Special Notice indicating its intent to award a sole source, firm fixed price purchase order to Life Technologies Corporation. This procurement is for the acquisition of reagent kits essential for clinical testing activities conducted at the NIH Clinical Center, located in Bethesda, Maryland.
The primary objective of this procurement is to ensure the continued availability of specialized reagent kits that are compatible with existing laboratory instrumentation within the DLM. Life Technologies Corporation, based at 3175 Staley Rd, Grand Island, NY 14072, is identified as the sole manufacturer, vendor, and service provider for these instruments and their associated reagents. As the exclusive developer and supplier, Life Technologies is the only source from which these critical reagents and supplies can be procured, ensuring seamless integration and reliable performance within the NIH’s clinical testing workflows.
This acquisition falls under Product Service Code 6515 (Medical Instruments, Equipment, and Supplies) and is classified within NAICS Code 339112 (Surgical and Medical Instrument Manufacturing), as per the 2022 NAICS version. The procurement is being conducted in accordance with Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, specifically Subpart 13.106-1(b)(1), which allows for solicitation from a single source when only one source is deemed reasonably available. As such, this action is exempt from the competition requirements outlined in FAR Part 6, and no set-aside provisions apply.
The NIH has emphasized that this is a notice of intent and not a request for quotation; therefore, no solicitation document will be issued, and quotations are not being requested. However, interested parties who believe they can fulfill the requirement are invited to express their interest and demonstrate their capabilities. The government retains sole discretion in determining whether to proceed with competition based on responses received.
The place of performance for this contract is Bethesda, Maryland (MD 20892), United States. The contracting activity is managed by the NIH Clinical Center’s Office of Purchasing and Contracts. All correspondence regarding this notice should reference procurement identifier 26-001503 and be directed to Kristin Nagashima, Contract Specialist, via email at [email protected]. The deadline for submitting comments or capability statements is March 25, 2026, at 9:00 AM EST.
This procurement represents a critical and ongoing requirement for the NIH Clinical Center, ensuring uninterrupted clinical testing operations through the supply of proprietary reagent kits from the only qualified source. Contractors considering this opportunity should note the sole source justification, the absence of set-aside or competitive requirements, and the specialized nature of the deliverables.